
A 2 × 2 factorial, randomised, open-label trial to determine the clinical and cost-effectiveness of hypertonic saline (HTS 6%) and carbocisteine for airway clearance versus usual care over 52 weeks in adults with bronchiectasis: a protocol for the CLEAR clinical trial
Bradley, Judy Martina, Anand, Rohan, O’Neill, Brenda, Ferguson, Kathryn, Clarke, Mike, Carroll, Mary, Chalmers, James, De Soyza, Anthony, Duckers, Jamie, Hill, Adam T., Loebinger, Michael R., CopelandVolume:
20
Journal:
Trials
DOI:
10.1186/s13063-019-3766-9
Date:
December, 2019
Fichier:
PDF, 1010 KB
2019